NO20043743L - Karboksylsyreforbindelser for anvendelse som overflateaktive midler - Google Patents

Karboksylsyreforbindelser for anvendelse som overflateaktive midler

Info

Publication number
NO20043743L
NO20043743L NO20043743A NO20043743A NO20043743L NO 20043743 L NO20043743 L NO 20043743L NO 20043743 A NO20043743 A NO 20043743A NO 20043743 A NO20043743 A NO 20043743A NO 20043743 L NO20043743 L NO 20043743L
Authority
NO
Norway
Prior art keywords
surfactants
carboxylic acid
acid compounds
compounds
carboxylic
Prior art date
Application number
NO20043743A
Other languages
English (en)
Norwegian (no)
Inventor
Alison Judith Redgrave
Brian Edgar Looker
Christopher James Lunniss
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0203363A external-priority patent/GB0203363D0/en
Priority claimed from GB0203369A external-priority patent/GB0203369D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20043743L publication Critical patent/NO20043743L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/04—Depilatories
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20043743A 2002-02-13 2004-09-07 Karboksylsyreforbindelser for anvendelse som overflateaktive midler NO20043743L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0203363A GB0203363D0 (en) 2002-02-13 2002-02-13 Novel compounds
GB0203369A GB0203369D0 (en) 2002-02-13 2002-02-13 Novel compounds
PCT/GB2003/000547 WO2003068722A1 (fr) 2002-02-13 2003-02-12 Composes d'acide carboxylique a utiliser comme agents de surface

Publications (1)

Publication Number Publication Date
NO20043743L true NO20043743L (no) 2004-09-07

Family

ID=27736206

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043743A NO20043743L (no) 2002-02-13 2004-09-07 Karboksylsyreforbindelser for anvendelse som overflateaktive midler

Country Status (17)

Country Link
US (1) US7217833B2 (fr)
EP (1) EP1474376A1 (fr)
JP (1) JP2005517701A (fr)
KR (1) KR20040086370A (fr)
CN (1) CN1633407A (fr)
AU (1) AU2003205860A1 (fr)
BR (1) BR0306976A (fr)
CA (1) CA2474626A1 (fr)
CO (1) CO5611094A2 (fr)
IL (1) IL162752A0 (fr)
IS (1) IS7336A (fr)
MX (1) MXPA04007899A (fr)
NO (1) NO20043743L (fr)
NZ (1) NZ533831A (fr)
PL (1) PL372106A1 (fr)
RU (1) RU2004120550A (fr)
WO (1) WO2003068722A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5172188B2 (ja) * 2007-03-28 2013-03-27 富士フイルム株式会社 フッ素置換アルキル基を有するグリセリド化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
US4535177A (en) * 1983-11-14 1985-08-13 Usv Pharmaceutical Corp. N-substituted amino acid derivatives
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69109284T2 (de) * 1990-03-23 1995-08-24 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe.
WO1992000062A1 (fr) 1990-06-27 1992-01-09 Minnesota Mining And Manufacturing Company Emploi de tensio-actifs fluores solubles dans la preparation de compositions pour aerosol doseur
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
CA2085884C (fr) 1990-06-29 2001-12-04 Asit Somani Compositions d'aerosol sous pression
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
HU219900B (hu) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Mért dózist adagoló inhalálóberendezés
US6376359B1 (en) 1998-03-18 2002-04-23 United Microelectronics Corp. Method of manufacturing metallic interconnect
US6451287B1 (en) * 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
WO2002024623A2 (fr) 2000-09-22 2002-03-28 Glaxo Group Limited Nouveaux derives d'acide alcanoique
EP1486203B1 (fr) 2001-08-03 2007-09-19 Glaxo Group Limited Composes agents de surface et leurs utilisations
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
IL162752A0 (en) 2005-11-20
WO2003068722A1 (fr) 2003-08-21
IS7336A (is) 2004-06-28
EP1474376A1 (fr) 2004-11-10
CN1633407A (zh) 2005-06-29
US20050163720A1 (en) 2005-07-28
NZ533831A (en) 2006-04-28
US7217833B2 (en) 2007-05-15
AU2003205860A1 (en) 2003-09-04
CA2474626A1 (fr) 2003-08-21
CO5611094A2 (es) 2006-02-28
JP2005517701A (ja) 2005-06-16
KR20040086370A (ko) 2004-10-08
BR0306976A (pt) 2004-12-14
RU2004120550A (ru) 2005-05-27
MXPA04007899A (es) 2004-10-15
PL372106A1 (en) 2005-07-11

Similar Documents

Publication Publication Date Title
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
NO20041339D0 (no) Spiro-hydantoin-forbindelser anvendelige som anti-inflammatoriske midler
NO20044256L (no) Makrosykliske forbindelser som kan anvendes som farmasoytika
NO20055680D0 (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
ATE368042T1 (de) Cephemverbindungen
NO20042955L (no) Substituerte fenylaftalener som estrogene midler
NO20031450L (no) Fumarsyrederivater som NF-kappa B inhibitorer
DK3494995T3 (da) Superfin formoterolformulering
NO20055370D0 (no) Alfa-substituert karboksylsyre som PPAR modulatorer
DK1651621T3 (da) 2-(Quinoxalin-5-ylsulfonylamino)benzamidforbindelser som CCK2-modulatorer
NO20024387L (no) Karboksylsyrederivater som IP-antagonister
ATE469878T1 (de) Aminobenzophenonverbindungen
ATE419250T1 (de) 2-cyanopyrrolidincarbonsäureamide als dipeptidylpeptidase-iv-inhibitoren
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
DK1660090T3 (da) Quinazolin-analoger som receptor-tyrosinkinase-inhibitorer
IS7414A (is) Oxó-azabísýklísk efnasambönd
NO20053753D0 (no) Karboksylsyreforbindelser.
NO20043794L (no) Benzensulfonamidderivater som antipsykotiske midler
NO20045659L (no) Forbindelser
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
DE50313212D1 (de) Blausäure aus formamid
DK1406888T3 (da) Substituerede gamma-lactonforbindelser som NMDA-antagonister
DE60324703D1 (de) Barbitursäure derivaten.
IS7943A (is) Ný amínóbensófenónefnasambönd